ABT vs BDX
Abbott Laboratories (ABT) and Becton Dickinson (BDX) compared side by side. Abbott Laboratories (ABT) is larger, with a market cap of $179.4B versus $54.2B for Becton Dickinson, about 3.3 times the size. On trailing earnings, ABT is cheaper at 38.6x versus 46.3x for BDX.
Head to head
| Metric | ABT | BDX |
|---|---|---|
| Market cap | $179.4B | $54.2B |
| P/E (TTM) | 38.6x | 46.3x |
| Forward P/E | 17.4x | 15.0x |
| Revenue (TTM) | $48.2B | $22.5B |
| Revenue growth | 14.5% | 5.4% |
| Gross margin | 57.1% | 46.9% |
| Operating margin | 11.3% | 15.7% |
| Free cash flow | $7.4B | $2.5B |
| Dividend yield | 2.43% | 2.11% |
| 1-year return | -15.9% | +39.0% |
| 5-year return (annual) | -2.0% | +2.8% |
| Max drawdown | -46% | -52% |
| FI Handbook grade | C+ | C+ |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
ABT vs BDX FAQ
Which is bigger, ABT or BDX?
Abbott Laboratories (ABT) is larger, with a market cap of $179.4B versus $54.2B for Becton Dickinson, about 3.3 times the size.
Is ABT or BDX cheaper?
On trailing earnings, ABT is cheaper at 38.6x versus 46.3x for BDX. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, ABT or BDX?
BDX returned +39.0% over the past year including dividends, versus -15.9% for ABT, through October 23, 2026.
Which pays a higher dividend, ABT or BDX?
ABT yields 2.43% versus 2.11% for BDX.
Full pages: Abbott Laboratories · Becton Dickinson